Search Results - "Bermudez, Carlos Daniel"

POSTER: CML-431 Second Line Treatment With Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) in Colombia. Report of the RENEHOC-ACHO Investigators by Polo, Virginia Abello, Melo, Claudia Lucia Sossa, Munevar, Isabel, Cuervo, Diana, Gomez, Rigoberto, Idrobo, Henry, Reyes, Jheremy, Borja, Yasmin, Quintero, Guillermo, Correa, Mario, Mantilla, William, Rosales, Carmen, Bermudez, Carlos Daniel, Galvez, Kenny Mauricio, Osuna, Monica, Serrano, Juan Carlos, Herrera, Juan Manuel, Saavedra, José Domingo, Gaviria, Lina María, Pedraza, Julia

Get full text

CML-431 Second Line Treatment With Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) in Colombia. Report of the RENEHOC-ACHO Investigators by Polo, Virginia Abello, Melo, Claudia Lucia Sossa, Munevar, Isabel, Cuervo, Diana, Gomez, Rigoberto, Idrobo, Henry, Reyes, Jheremy, Borja, Yasmin, Quintero, Guillermo, Correa, Mario, Mantilla, William, Rosales, Carmen, Bermudez, Carlos Daniel, Galvez, Kenny Mauricio, Osuna, Monica, Serrano, Juan Carlos, Herrera, Juan Manuel, Saavedra, José Domingo, Gaviria, Lina María, Pedraza, Julia

“…TKIs have changed the history of CML, achieving a life expectancy similar to that of the general population. However, a significant percentage of patients will…”
Get full text

MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry by Martinez-Cordero, Humberto, Abello-Polo, Virginia, Casas, Claudia, Solano, Maria-Helena, Espinosa, Daniel, Perdomo, Ivan, Reyez, Jheremy, Osuna, Monica, Paredes, Viviana, Figueroa, Jair, Gomez, Rigoberto, Jaramillo, Roberto, Gomez, Alvaro, Saavedra, Jose-Domingo, Galvez, Kenny, Quintero, Guillermo, Abenoza, Lina, Gaviria, Lina, Borjas, Yazmin, Idrobo, Henry, Mantilla, William, Sossa, Claudia, Salazar, Luis, Herrera, Juan-Manuel, Guerrero, Paola, Guerrero, Alvaro, Rosales, Carmen, Munevar, Isabel, Bermudez, Carlos-Daniel

“…The most frequently used induction treatments for newly diagnosed multiple myeloma in Colombia are VTD and CyBorD for transplant-eligible patients. At present,…”
Get full text

Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry by Martinez-Cordero, Humberto, Abello-Polo, Virginia, Casas, Claudia, Solano, Maria-Helena, Espinosa, Daniel, Perdomo, Ivan, Reyez, Jheremy, Osuna, Monica, Paredes, Viviana, Figueroa, Jair, Gomez, Rigoberto, Jaramillo, Roberto, Gomez, Alvaro, Saavedra, Jose-Domingo, Galvez, Kenny, Quintero, Guillermo, Abenoza, Lina, Gaviria, Lina, Borjas, Yazmin, Idrobo, Henry, Mantilla, William, Sossa, Claudia, Salazar, Luis, Herrera, Juan-Manuel, Guerrero, Paola, Guerrero, Alvaro, Rosales, Carmen, Munevar, Isabel, Bermudez, Carlos-Daniel

Get full text

Frontline Therapy with Low Risk Chemotherapy (R-CVP/R-CHOP) in Follicular B-Cell Lymphoma Recently Diagnosed. Clinical Experience in Two Centers of Bogotá, Colombia by Bermudez, Carlos Daniel, Suarez, Martha Leticia, Cancelado, Sergio Andres, Ramirez, Carlos Alberto

“…Abstract 4893 The follicular lymphoma (FL) it is a subset of non-Hodgkin lymphomas, accounting for between 15% and 30% of new diagnoses of lymphoma. It has…”
Get full text

PILLAR-2: A randomized, double-blind, placebo-controlled, phase III study of adjuvant everolimus (EVE) in patients (pts) with poor-risk diffuse large B-cell lymphoma (DLBCL) by Witzig, Thomas E., Tobinai, Kensei, Rigacci, Luigi, Lin, Tongyu, Ikeda, Takashi, Vanazzi, Anna, Hino, Masayuki, Shi, Yuankai, Mayer, Jiri, Costa, Luciano J, Bermudez, Carlos DANIEL, Zhu, Jun, Belada, David, Bouabdallah, Kamal, Kattan, Joseph Gergi, Wu, Cassandra, Fan, Jenna, Louveau, Anne-Laure, Voi, Maurizio, Cavalli, Franco

“…Abstract only…”
Get full text

Treatment-Free Remission (TFR) Is Feasible in Clinical Practice Latin-America (LA): A Real-World Cohort of Patients in Colombia by Abello, Virginia, Munevar, Isabel, Gomez, Rigoberto, Osuna Pérez, Monica, Bermudez Silva, Carlos Daniel, Borjas, Yasmin, Sossa, Claudia Lucia

“…BACKGROUND: Long-term Tirosin Kinase Inhibitor (TKI) treatment is related to notable adverse events, quality-of-life impact and significant costs to health…”
Get full text

Clinical Features and Prognostic Factors in Multiple Myeloma Patients from Colombia. Real-World Data from Renehoc Registry by Pedraza, Julian, Claudia, Sossa-Melo, Cuervo, Diana, Martinez-Cordero, Humberto, Quintero, Henry Idrobo, Salazar, Luis Antonio, Galvez, Kenny, Quintero, Guillermo, Munevar, Isabel, Mantilla, William, Borjas, Yasmin, Gomez Gutierrez, Rigoberto, Reyes, Jheremy, Domingo Saavedra, Jose, Gaviria, Lina María, Guerrero, Paola, Correa, Mario Ernesto, Serrano, Juan Carlos, Pérez, Mónica Osuna, Bermudez Silva, Carlos Daniel, Herrera, Juan Manuel, Abello, Virginia

“…Background: The prognosis for patients with multiple myeloma (MM) has improved over time, but there is considerable heterogeneity in disease outcomes…”
Get full text

Impact of Sociodemographic and Clinical Factors on the Survival of Patients with Acute Myeloid Leukemia: A Multicenter Experience in Colombia, on Behalf of Acho's Renehoc-Pethema Investigators by Sossa, Claudia Lucia, Abello, Virginia, Peña, Angela María, Salazar, Luis Antonio, Quintero Vega, Guillermo, Mantilla Duran, William Armando, Idrobo, Henry, Reyes Castellanos, Jheremy Enrique, Gaviria, Lina, Bermudez Silva, Carlos Daniel, Gomez, Rigoberto, Correa, Mario Ernesto, Guerrero, Paola, Sandoval-Sus, Jose, Martínez-Cuadrón, David, Sanz, Miguel A., Montesinos, Pau

“…Introduction: Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults, accounting for almost 80 percent of the cases. Incidence of AML…”
Get full text

Outcomes after First Rescue Treatment in Patients with Relapsed or Refractory Multiple Myeloma in Colombia by Martinez-Cordero, Humberto, Abello, Virginia, Mantilla Duran, William Armando, Gomez, Rigoberto, Reyes, Jheremy, Idrobo, Henry, Galvez, Kenny, Casas, Claudia Patricia, Solano, Maria Helena, Espinosa, Daniel, Amar, Ivan Alfredo Perdomo, Osuna Pérez, Monica, Gomez Diaz, Alvaro, Saavedra, Domingo, Quintero, Guillermo, Abenoza, Lina, Gaviria, Lina, Henao-Uribe, Alicia, Sossa, Claudia Lucia, Rosales, Carmen, Paredes, Claudia, Figueroa Emiliani, Jair, Munevar, Isabel, Bermudez Silva, Carlos Daniel, Borjas, Yasmin, Guerrero, Alvaro, Guerrero, Paola, Herrera, Juan Manuel

“…Background Proteasome inhibitors (PIs) are approved for treating newly diagnosed and relapsed multiple myeloma (MM) in Colombia. This propensity score matching…”
Get full text

Costo- Efectividad Del Uso Profiláctico Del Factor Estimulante De Colonias De Granulocitos En Adultos Con Leucemia Linfoblástica Aguda en Colombia by Casadiego Rincón, Elkin Javier, Díaz Rojas, Jorge Augusto, Bermúdez, Carlos Daniel, Martínez, Víctor Prieto

“…To assess the cost-effectiveness of prophylactic administration of Granulocyte Colony-Stimulating Factor (G-CSF) compared with no use of it, during the…”
Get full text